SK287045B6 - Taxánový derivát, spôsob jeho prípravy, farmaceutický prostriedok s jeho obsahom, jeho použitie a medziprodukty - Google Patents

Taxánový derivát, spôsob jeho prípravy, farmaceutický prostriedok s jeho obsahom, jeho použitie a medziprodukty Download PDF

Info

Publication number
SK287045B6
SK287045B6 SK1-2002A SK12002A SK287045B6 SK 287045 B6 SK287045 B6 SK 287045B6 SK 12002 A SK12002 A SK 12002A SK 287045 B6 SK287045 B6 SK 287045B6
Authority
SK
Slovakia
Prior art keywords
carbonate
iii
hydroxy
solution
derivative
Prior art date
Application number
SK1-2002A
Other languages
English (en)
Slovak (sk)
Other versions
SK12002A3 (en
Inventor
Ezio Bombardelli
Bruno Gabetta
Alessandro Pontiroli
Original Assignee
Indena S. P. A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena S. P. A. filed Critical Indena S. P. A.
Publication of SK12002A3 publication Critical patent/SK12002A3/sk
Publication of SK287045B6 publication Critical patent/SK287045B6/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08Bridged systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/10Spiro-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D263/06Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SK1-2002A 1999-07-06 2000-07-03 Taxánový derivát, spôsob jeho prípravy, farmaceutický prostriedok s jeho obsahom, jeho použitie a medziprodukty SK287045B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999MI001483A ITMI991483A1 (it) 1999-07-06 1999-07-06 Derivati tassanici e procedimenti per la loro preparazione
PCT/EP2000/006185 WO2001002407A2 (en) 1999-07-06 2000-07-03 Taxane derivatives and processes for the preparation thereof

Publications (2)

Publication Number Publication Date
SK12002A3 SK12002A3 (en) 2002-04-04
SK287045B6 true SK287045B6 (sk) 2009-10-07

Family

ID=11383284

Family Applications (2)

Application Number Title Priority Date Filing Date
SK1-2002A SK287045B6 (sk) 1999-07-06 2000-07-03 Taxánový derivát, spôsob jeho prípravy, farmaceutický prostriedok s jeho obsahom, jeho použitie a medziprodukty
SK5033-2009A SK287046B6 (sk) 1999-07-06 2000-07-03 Spôsob prípravy oxazolidínového medziproduktu na syntézu taxánových derivátov

Family Applications After (1)

Application Number Title Priority Date Filing Date
SK5033-2009A SK287046B6 (sk) 1999-07-06 2000-07-03 Spôsob prípravy oxazolidínového medziproduktu na syntézu taxánových derivátov

Country Status (23)

Country Link
US (2) USRE40901E1 (pt)
EP (2) EP1529777B1 (pt)
JP (1) JP4823456B2 (pt)
KR (1) KR100778156B1 (pt)
CN (3) CN1234696C (pt)
AT (2) ATE277932T1 (pt)
AU (1) AU771737B2 (pt)
CA (2) CA2373530C (pt)
CZ (1) CZ301764B6 (pt)
DE (2) DE60032827T2 (pt)
DK (2) DK1529777T3 (pt)
ES (2) ES2278254T3 (pt)
HK (3) HK1047096A1 (pt)
HU (1) HUP0202016A3 (pt)
IL (3) IL147445A0 (pt)
IT (1) ITMI991483A1 (pt)
NO (2) NO328150B1 (pt)
PL (1) PL205921B1 (pt)
PT (2) PT1192162E (pt)
RU (1) RU2245882C2 (pt)
SI (2) SI1529777T1 (pt)
SK (2) SK287045B6 (pt)
WO (1) WO2001002407A2 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1318678B1 (it) * 2000-08-10 2003-08-27 Indena Spa Procedimento per la preparazione di derivati della baccatina iii.
IT1320107B1 (it) * 2000-11-28 2003-11-18 Indena Spa Procedimento per la preparazione di derivati tassanici.
ITMI20021921A1 (it) * 2002-09-10 2004-03-11 Indena Spa Funzionalizzazione della posizione 14 dei nuclei tassanici e sintesi di nuovi derivati antitumorali.
US8557861B2 (en) * 2004-09-28 2013-10-15 Mast Therapeutics, Inc. Low oil emulsion compositions for delivering taxoids and other insoluble drugs
TWI376239B (en) * 2006-02-01 2012-11-11 Andrew Xian Chen Vitamin e succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof
US7232916B1 (en) * 2006-05-11 2007-06-19 Indena S.P.A. Process for the preparation of a taxane derivative
EP1854799B1 (en) * 2006-05-12 2011-04-27 INDENA S.p.A. Process for the preparation of a taxane derivative
ITMI20062479A1 (it) * 2006-12-21 2008-06-22 Indena Spa Processo per la preparazione di secotassani
EP2080764B1 (en) * 2008-01-18 2012-08-22 INDENA S.p.A. Solid forms of ortataxel
EP2080763A1 (en) 2008-01-18 2009-07-22 INDENA S.p.A. Crystalline form I of ortataxel
CN104650109B (zh) * 2013-11-22 2019-01-01 江苏天士力帝益药业有限公司 紫杉烷类化合物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9102128A (es) 1990-11-23 1992-07-08 Rhone Poulenc Rorer Sa Derivados de taxano,procedimiento para su preparacion y composicion farmaceutica que los contiene
US5698712A (en) * 1992-03-06 1997-12-16 Indena S.P.A. Baccatine III derivatives
FR2688499B1 (fr) 1992-03-10 1994-05-06 Rhone Poulenc Rorer Sa Procede de preparation de la beta-phenylisoserine et de ses analogues.
FR2696460B1 (fr) * 1992-10-05 1994-11-25 Rhone Poulenc Rorer Sa Procédé de préparation de dérivés du taxane.
US5475011A (en) * 1993-03-26 1995-12-12 The Research Foundation Of State University Of New York Anti-tumor compounds, pharmaceutical compositions, methods for preparation thereof and for treatment
US5750508A (en) 1993-06-16 1998-05-12 Glycomed Incorporated Sialic acid/fucose based medicaments
IT1275936B1 (it) * 1995-03-17 1997-10-24 Indena Spa Derivati della 10-deacetilbaccatina iii e della 10-deacetil-14b- idrossibaccatina iii loro metodo di preparazione e formulazioni

Also Published As

Publication number Publication date
JP2003503502A (ja) 2003-01-28
SI1529777T1 (sl) 2007-04-30
KR100778156B1 (ko) 2007-11-27
EP1192162A2 (en) 2002-04-03
ES2278254T3 (es) 2007-08-01
DE60014374D1 (de) 2004-11-04
SK287046B6 (sk) 2009-10-07
CA2373530C (en) 2010-06-29
CN1158286C (zh) 2004-07-21
CA2676424C (en) 2011-09-27
US6906101B1 (en) 2005-06-14
IL147445A0 (en) 2002-08-14
ATE350372T1 (de) 2007-01-15
EP1192162B1 (en) 2004-09-29
HK1047096A1 (en) 2003-02-07
NO20020017D0 (no) 2002-01-03
CN100418958C (zh) 2008-09-17
NO20020017L (no) 2002-02-27
IL172973A0 (en) 2006-06-11
CA2676424A1 (en) 2001-01-11
CN1234696C (zh) 2006-01-04
DK1529777T3 (da) 2007-05-14
DK1192162T3 (da) 2005-01-17
HUP0202016A2 (en) 2002-10-28
RU2245882C2 (ru) 2005-02-10
CN1769275A (zh) 2006-05-10
EP1529777A2 (en) 2005-05-11
EP1529777B1 (en) 2007-01-03
AU5823500A (en) 2001-01-22
WO2001002407A2 (en) 2001-01-11
ITMI991483A0 (it) 1999-07-06
PL205921B1 (pl) 2010-06-30
DE60032827D1 (de) 2007-02-15
CN1359384A (zh) 2002-07-17
USRE40901E1 (en) 2009-09-01
CZ200222A3 (cs) 2002-05-15
PT1529777E (pt) 2007-01-31
AU771737B2 (en) 2004-04-01
CA2373530A1 (en) 2001-01-11
SI1192162T1 (en) 2005-02-28
WO2001002407A3 (en) 2001-06-28
HK1068879A1 (en) 2005-05-06
DE60032827T2 (de) 2007-11-08
EP1529777A3 (en) 2005-05-18
IL147445A (en) 2006-07-05
SK12002A3 (en) 2002-04-04
NO328150B1 (no) 2009-12-21
PT1192162E (pt) 2004-12-31
DE60014374T2 (de) 2006-02-16
IL172973A (en) 2010-11-30
CN1539831A (zh) 2004-10-27
ATE277932T1 (de) 2004-10-15
HK1089158A1 (en) 2006-11-24
PL352278A1 (en) 2003-08-11
CZ301764B6 (cs) 2010-06-16
ES2228560T3 (es) 2005-04-16
HUP0202016A3 (en) 2005-02-28
NO332194B1 (no) 2012-07-23
ITMI991483A1 (it) 2001-01-06
KR20020022759A (ko) 2002-03-27
NO20093014L (no) 2002-02-27
JP4823456B2 (ja) 2011-11-24

Similar Documents

Publication Publication Date Title
KR100317015B1 (ko) 7-할로탁솔및7베타,8베타-메타노탁솔,그를함유하는약학조성물및항종양제로서의그의용도
KR100378972B1 (ko) 델타12,13-이소-탁솔유사체,항종양제용도및그를함유하는약학조성물
HU225294B1 (en) Oxazoline derivatives for synthesis of sidechain-bearing taxanes and preparation thereof
US20160331718A1 (en) 9, 10-alpha, alpha-oh-taxane analogs and method for production thereof
JPH09511212A (ja) Δ▲上6▼,▲上7▼−タキソール類の抗悪性腫瘍的使用およびそれらを含む医薬組成物
NO332194B1 (no) Prosess og oxazolidinintermediat for syntese av taxaner
JP2008515840A (ja) 10−デアセチル−n−デベンゾイル−パクリタキセルの製造のための半合成方法
KR100847331B1 (ko) 도세탁셀의 제조방법 및 이에 사용되는 중간체
KR100545436B1 (ko) 파크리탁셀과 그 동족체의 반합성에 유용한 중간체와 그제조방법
KR20050035540A (ko) 14번-위치에서 기능화된 탁산유도체 및 그의 제조방법

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20100703